FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/03/012305 [Registered on: 05/03/2018] Trial Registered Retrospectively
Last Modified On: 13/02/2018
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cosmaceutical]  
Study Design  Other 
Public Title of Study   Testing of safety and effectiveness of Under eye serum and anti aging under eye serum  
Scientific Title of Study   A study to evaluate the Opthalmologic and Dermatologic safety of the Under Eye Serums by Repeat Use Test (7 days) in Healthy Subjects with Equal Representation of Different Skin Types. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
MSCR/ITUE/2016-03, Version 1.0 dated 22 Apr 2016  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sapna R 
Designation  Principal Investigator 
Affiliation  MS Clinical Research Pvt Ltd 
Address  327/15, 1st Main Road Cambridge layout, Ulsoor Bangalore-560008, Karnataka, India

Bangalore
KARNATAKA
560008
India 
Phone  918040917253  
Fax  918041125934  
Email  sapna.r@mscr.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sapna R 
Designation  Principal Investigator 
Affiliation  MS Clinical Research Pvt Ltd 
Address  327/15, 1st Main Road Cambridge layout, Ulsoor Bangalore-560008, Karnataka, India


KARNATAKA
560008
India 
Phone  918040917253  
Fax  918041125934  
Email  sapna.r@mscr.in  
 
Details of Contact Person
Public Query
 
Name  Ritambhara 
Designation  Manager 
Affiliation  MS Clinical Research Pvt Ltd 
Address  327/15, 1st Main Road Cambridge layout, Ulsoor Bangalore-560008, Karnataka, India

Bangalore
KARNATAKA
560008
India 
Phone  918040917253  
Fax  918041125934  
Email  ritambhara@mscr.in  
 
Source of Monetary or Material Support  
Sponsor:ITC Life Sciences & Technology Centre, Peenya Industrial area, I Phase, Peenya Bangalore- 560058 Karnataka, India  
 
Primary Sponsor  
Name  ITC Life Sciences Technology Centre 
Address  Peenya Industrial area, I Phase, Peenya Bangalore- 560058 Karnataka, India 
Type of Sponsor  Other [FMCG (Fast Moving Consumer Goods)] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sapna R  MS Clinical Research Pvt Ltd  Dermalogical Evaluation room, first floor, 327/15, 1st main road , cambridge layout ulsoor, Bangalore- 560008.
Bangalore
KARNATAKA 
918040917253
918041125934
sapna.r@mscr.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Clinicom Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  varied eye conditions such as normal condition, sensitive condition and contact lens users 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1) Under eye serum 2) Antiaging under eye serum  Dose: One drop is to be dispensed on the fingertip and gently massaged over the under eye area and lateral canthus /crows-feet/ outer corners of the eye till it gets absorbed completely. Frequency:Twice Daily Route of administration: Topical Application Duration of therapy: 1 week for each subject 
Comparator Agent  None  None 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1.Subjects in generally good health.
2.Subjects willing to abide by the study requirements and protocol.
Special criteria:
3.Equal representation of subjects with visible Finelines and / or Wrinkles, Under Eye Puffiness and Under eye dark circles in both groups
4.Atleast 18 Subjects with visible Finelines and / or Wrinkles
5.Atleast 18 Subjects with Under Eye Puffiness
6.Atleast 18 Subjects with Under Eye Dark circles
7.Equal representation of different skin types- Normal, Oily, Dry and Combination Sensitive.
8.Subjects of varied eye conditions such as normal condition, sensitive condition and contact lens users
 
 
ExclusionCriteria 
Details  1.Women subjects who are pregnant or lactating
2.A known history or present condition of allergic response to any cosmetic products (eye/ facial cosmetic products).
3.Subjects having eye infection or allergy.
4.Subjects having extremely sensitive eye condition.
5.Subjects having any form cutaneous disease which may influence the study result.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate the Ophthalmologic and Dermal safety of the test products in causing no ocular irritation or dermal irritation on repeated use of test products involving subjects of varied eye conditions such as normal condition, sensitive condition and contact lens users.To evaluate the product sensorials and post use skin sensorials and efficacy during one week use.  Approximately 1 week for each subject 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "72"
Final Enrollment numbers achieved (India)="72" 
Phase of Trial   N/A 
Date of First Enrollment (India)   13/05/2016 
Date of Study Completion (India) 30/06/2016 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Study Objective: To evaluate the Ophthalmologic and Dermal safety of the test products in causing no ocular irritation or dermal irritation on repeated use of test products involving subjects of varied eye conditions such as normal condition, sensitive condition and contact lens users.To evaluate the product sensorials and post use skin sensorials and efficacy during one week use.Study Duration: 7 days for each subject. Study Population : 70 male and female subjects with varied eye conditions such as normal condition, sensitive condition and contact lens users. Age: 25 to 50 years. Product Dosage: One drop is to be dispensed on the fingertip and gently massaged over the under eye area and lateral canthus /crows-feet/ outer corners of the eye till it gets absorbed completely.Twice daily application during day and night on cleaned under-eye region and for 1 week. Assessments:Dermatological Assessment, Ophthalmologic Assessment and subject self assessment.

Results: Anti aging serum (AA-43) and Mens under serum (MN-38) caused no ocular irritation at any of he studied time points. Mean irritation score also indicates that the product is non irritant. Anti aging serum (AA-43) caused no dermal irritation at the studied time points. However dermats observed mild shiny appearance of skin in some subjects. The shiny appearance subsided within a week before the subjects returned to the next visit. No discomfort was observed. Based on statistical analysis and subjects feedback  it can be concluded with significance that more than 95 % of the study participants liked Mens under Eye serum (MN-38) for its color, appearance, spread ability, glossiness, thickness and skin oily feel. It also contributed in skin moisturization, softness, smothness and firmness under the eye region. It helped in reducing under eye dark circle intensity, eye puffiness and youthful appearance. It has helped in to fight with early signs of aging and reduces finelines and wrinkles. It relaxes, distresses, revives and refreshes the skin. The participants liked overall senosrials.

 
Close